06 October 2021. Central Epidemic Command Center (CECC) said that Taiwan has been active in trying to secure molnupiravir, an oral antiviral pill for treating COVID-19. The CECC will introduce the drug to the country once its application for an emergency use authorization (EUA) is approved by the U.S. Food and Drug Administration (FDA).https://www.taiwannews.com.tw/en/news/4307846